![Bryan B. Sendrowski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bryan B. Sendrowski
Directeur/Membre du Conseil chez
MELINTA THERAPEUTICS, INC.
Profil
Bryan B. Sendrowski currently works at Endologix LLC, as Director, Chondrial Therapeutics, Inc., as Director, Melinta Therapeutics, Inc., as Director from 2020, Chondrial Therapeutics Holdings LLC, as Director, and Deerfield Management Co. LP (Private Equity), as Partner and Head of Corporate Finance from 2012.
Mr. Sendrowski also formerly worked at Reliant Pharmaceuticals LLC, as Controller & Vice President from 2004 to 2008, Akrimax Pharmaceuticals LLC, as Chief Financial Officer from 2008 to 2010, and New American Therapeutics, Inc., as Chief Financial Officer from 2010 to 2012.
Mr. Sendrowski received his undergraduate degree in 1997 from Pace University.
Postes actifs de Bryan B. Sendrowski
| Sociétés | Poste | Début |
|---|---|---|
| MELINTA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 20/04/2020 |
| ENDOLOGIX, INC. | Directeur/Membre du Conseil | - |
Chondrial Therapeutics, Inc.
 Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops orphan drugs for mitochondrial diseases | Directeur/Membre du Conseil | - |
Chondrial Therapeutics Holdings LLC
 Chondrial Therapeutics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Directeur/Membre du Conseil | - |
Deerfield Management Co. LP (Private Equity)
 Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management invests in both private and public companies located in the United States. The firm targets companies operating in the fields of diagnostic, digital health, life science, medical device, and health care services. It provides financing for pre-seed, seed, early, later and growth stage capital requirements. | Private Equity Investor | 01/10/2012 |
Anciens postes connus de Bryan B. Sendrowski
| Sociétés | Poste | Fin |
|---|---|---|
New American Therapeutics, Inc.
 New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapeutic medicines | Directeur Financier/CFO | 01/10/2012 |
Akrimax Pharmaceuticals LLC
 Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures medicines for metabolic syndrome | Directeur Financier/CFO | 01/09/2010 |
Reliant Pharmaceuticals LLC
 Reliant Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Comptroller/Controller/Auditor | 01/03/2008 |
Formation de Bryan B. Sendrowski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
86
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Endologix LLC
 Endologix LLC Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices for the interventional treatment of vascular disease | Health Technology |
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Akrimax Pharmaceuticals LLC
Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures medicines for metabolic syndrome | Health Technology |
Chondrial Therapeutics, Inc.
Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops orphan drugs for mitochondrial diseases | Health Technology |
Pace University
 Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New American Therapeutics, Inc.
New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapeutic medicines | Health Technology |
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management invests in both private and public companies located in the United States. The firm targets companies operating in the fields of diagnostic, digital health, life science, medical device, and health care services. It provides financing for pre-seed, seed, early, later and growth stage capital requirements. | Finance |
Melinta Therapeutics, Inc.
 Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage company and develops innovative therapies for acute and life-threatening illnesses | Health Technology |
Chondrial Therapeutics Holdings LLC
Chondrial Therapeutics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
